Effects of low-fluence rate PDT on glioma spheroids

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 4612, Issue , 2002, Pages 190-195

  Madsen, Steen J ^a   Rodenbush, Robin M ^a   Sun, Chung Ho ^a   Tromberg, Bruce J ^a   Hirschberg, Henry ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

5 Aminolevulinic Acid; Fluence rate; Glioma spheroids; Hexyl ALA; Photodynamic Therapy

Indexed keywords

DERIVATIVES; ESTERS; PHOTOSENSITIZERS; PORPHYRINS; SKIN; TUMORS;

FLUENCE RATES;

PHOTODYNAMIC THERAPY;

EID: 0036400081     PISSN: 0277786X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.469347     Document Type: Conference Paper

References (12)

1. M. Salcman, "Epidemiology and factors affecting survival,"in Malignant Cerebral Glioma, M.L.J. Apuzzo, Ed. Amercian Association of Neurological Surgeons, pp. 95-109, 1990.
2. K.E. Wallner, J.H. Galicich, G. Krol, E. Arbit and M.G. Malkin, "Patterns of failure following treatments for glioblastoma multiforme and anaplastic astrocytoma," Int. J. Radiat. Oncol. Biol. Phys. 16, pp. 1405-09, 1989.
3. P.J. Muller and B.C. Wilson, "Photodynamic therapy for recurrent supratentorial gliomas," Semin. Surg. Oncol. 11, pp. 346-54, 1995.
4. E. Papovic, A. Kaye and J. Hill, "Photodynamic therapy of brain tumors," J. Clin. Laser Radiat. Surg. 14, pp. 251-62, 1996.
5. J. Kloek and G.M.J. Beijersbergen van Henegouwen, "Prodrugs of 5-aminolevulinic acid for photodynamic therapy," Photochem. Photobiol. 64, pp. 994-1000, 1996.
6. L.A. Svensson, "Prodrugs: metabolism-based drug design," Pharm. Weekbl. 122, 245-250, 1987.
7. P. Uehlinger, M. Zellweger, G. Wagnieres, L. Juillerat-Jeanneret, H. van den Bergh and N. Lange, "5-aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells," J. Photochem. Photobiol. B: Biol. 54, pp. 72-80, 2000.
8. S.J. Madsen, C.-H. Sun, B.J. Tromberg, V.P. Wallace and H. Hirschberg, "Photodynamic therapy of human glioma spheroids using 5-aminolevulinic acid," Photochem. Photobiol. 72(1), pp. 128-34, 2000.
9. S.J. Madsen, L.O. Svaasand, B.J. Tromberg, and H. Hirschberg, "Characterization of optical and thermal distributions from an intracranial balloon applicator for photodynamic therapy," Proc. SPIE 4257, pp. 41-49, 2001.
10. Q. Peng, T. Warloe, K. Berg, J. Moan, M. Kongshaug, K.-E. Giercksky and J.M. Nesland, "5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges," Cancer 79, pp. 2282-2308, 1997.
11. J.-M. Gaullier, K. Berg, Q. Peng, H. Anholt, P.K. Selbo, L.-W. Ma and J. Moan, "Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture," Cancer Res. 57, pp. 1481-1486, 1997.
12. J. Webber, D. Kessel, and D. Fromm, "Side effects and photosensitization of human tissues after aminolevulinic acid," J. Surg. Res. 68, pp. 31-37, 1997.